Medical and Pharmaceutical Health Canada approves Zepbound for obstructive sleep apnea in adults with obesity The disorder can cause excessive daytime sleepiness and increase the risk of serious health problems Joseph MortonJune 24, 2026
Medical and Pharmaceutical Expanding access: LillyDirect offers Zepbound directly to patients Eli Lilly introduces direct-to-patient portal for obesity drug access Zartasha MushtaqFebruary 9, 2024